Many effective interventions that improve HIV outcomes for Black men who have sex with men exist – now they need to be scaled up
Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter
One dose of TAF every three days gets more drug into cells than a daily dose of TDF
Dolutegravir-based regimens result in sustained viral suppression, despite lower adherence and treatment interruptions
Adolescent-centred interventions lead to a 30-percentage-point increase in viral suppression in Namibia, and a 20-percentage-point increase in Nigeria
Healthcare workers in Cape Town ambivalent about patients who disengage from HIV treatment
People with NNRTI resistance have poorer responses to dolutegravir, South African study finds
Injectable HIV therapy should save money if adherence is better than to oral therapies
Poor adherence associated with disruptive life events in young people living with HIV
